The 21st century has ushered in a new age where all aspects of our lives are impacted by technology. How will humanity anticipate, mitigate, and manage the consequences of AI, robots, quantum computing and more? How do we ensure tech works for the good of all? This Ashoka series sheds light on the wisdom and ideas of leaders in the field.
Dr. Stephen Friend is a globally acclaimed serial entrepreneur and biomedical researcher. He currently is the President and co-founder of 4YouandMe, a visiting Professor of Connected Medicine at Oxford University and Chairman of the Board of Directors of Sage Bionetworks, where he was co-founder and President. He previously held positions at Apple, was Senior Vice President at Merck & Co, founded and led Rosetta Impharmatics, and was an Associate Professor at Harvard Medical School. He was elected an Ashoka Fellow in 2011. Before venturing into medicine and cancer research, he studied anthropology and philosophy.
Konstanze Frischen (Ashoka): Stephen, how can AI help us live healthier?
Stephen Friend: It’s simple: Wearable devices – rings or watches that register heartbeat and all kinds of other physiological data – today can allow individuals to follow themselves. But the potential is bigger: What we are betting on is that we can use AI and machine learning to analyze these data in ways that better track stress and individual symptoms so we can forecast the onset or worsening of chronic diseases like migraines, MS, Crohn’s disease, or even vulnerable times of metamorphosis, like pregnancy or menopause.
KF: And what are you learning?
SF: We are learning how to collect multidimensional, longitudinal data on chronic illnesses – and the results are remarkably strong. An individual’s physiological data – variable heart rate, breathing patterns, skin tone, and much more – yield patterns that correlate with flares of symptoms. And we are setting up studies to test if the more centered a person is in themselves, the lesser the degree of their illness. Conversely, we can see that stress is a breeding ground for symptoms.
KF: So, the data generated by wearables show that our states of mind like stress or wellbeing are underpinned by physiological markers that correspond to diseases?
SF: Yes, this is what we expect to verify. The signals are numerous, and in unison. The body has a way of responding to stress that changes your voice, blood pressure, sleep, what’s going on in your pancreas, your sweat and so on. And the ability to pick these data sets up and stick all of them together, means we can get a pretty good idea of how someone is doing and can start to make individual forecasts for a patient when a disease is likely to start or flare up.
Image Credit: New York Times
News This Week
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six different materials and eight segments, [...]